metronidazole has been researched along with cilastatin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (19.05) | 18.7374 |
| 1990's | 10 (47.62) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Heikkinen, E; Seppänen, J; Uhari, M | 1 |
| Bellantone, R; Brisinda, G; Crucitti, F; Doglietto, GB; Pacelli, F | 1 |
| Christensen, FB; French, JI; McGregor, JA | 1 |
| Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ | 1 |
| Burkitt, DS; Donovan, IA; Lowe, P; Wise, R | 1 |
| Broze, B; de Lame, PA; De Mees, J; Droissart, R; Nolens, VP; Staudt, JP; Verstraeten, ME | 1 |
| Johnson, E; Kennedy, RH; Leaper, DJ; Roberts, N; Sutton, A | 1 |
| Avery, D; Kennedy, R; Leaper, D; Leow, C; Thomas, W | 1 |
| Bjornson, HS; Bohnen, JM; Coulter, HO; Dellinger, EP; Echols, RM; Haverstock, DC; Hill, CS; Reinhart, HH; Rotstein, OD; Simms, HH; Solomkin, JS; Vogel, SB | 1 |
| Angerås, MH; Darle, N; Ekelund, M; Engström, L; Hamnström, K; Holme, JB; Takala, J; Viste, A | 1 |
| Bossuyt, M; De Backer, T; Schoenaers, J | 1 |
| Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY | 1 |
| Paladino, JA; Solomkin, JS; Walters, DJ | 1 |
| Blasco Huelva, A; González Palomino, A; Keituqwa Yáñez, T; Marcos García, M; Pardo Romero, G; Píno Rivero, V; Trinidad Ruiz, G | 1 |
| Barie, PS; Dellinger, EP; Grasela, TH; Rotstein, OD; Walawander, CA | 1 |
| Caviezel, A; Garbino, J; Lew, D; Matulionyte, R; Morel, P; Uckay, I; Villiger, P | 1 |
| Chen, C; Chen, K; Dong, N; Hu, D; Huang, J; Jin, X; Li, Y; Xie, Y | 1 |
13 trial(s) available for metronidazole and cilastatin
| Article | Year |
|---|---|
Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
Topics: Adolescent; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Metronidazole; Tobramycin | 1992 |
Single dose imipenem-cilastatin compared with three doses of cefuroxime and metronidazole as prophylaxis in elective colorectal surgery: a prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefuroxime; Cilastatin; Colorectal Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Postoperative Complications; Premedication; Prospective Studies | 1991 |
Intramuscular imipenem/cilastatin treatment of upper reproductive tract infection in women: efficacy and use characteristics.
Topics: Cesarean Section; Cilastatin; Cilastatin, Imipenem Drug Combination; Consumer Behavior; Costs and Cost Analysis; Drug Administration Schedule; Drug Combinations; Endometritis; Female; Humans; Imipenem; Injections, Intramuscular; Metronidazole; Patient Compliance; Pelvic Inflammatory Disease | 1991 |
A comparison between imipenem and metronidazole prophylaxis against sepsis following appendicectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Appendectomy; Child; Cilastatin; Drug Combinations; Emergencies; Humans; Imipenem; Infusions, Intravenous; Metronidazole; Middle Aged; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Surgical Wound Infection | 1990 |
Imipenem/cilastatin as monotherapy in severe infections: comparison with cefotaxime in combination with metronidazole and cloxacillin. Report from a Norwegian Study Group.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cloxacillin; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Metronidazole; Random Allocation; Thienamycins | 1987 |
Randomized comparison of imipenem/cilastatin and ceftazidime in the empiric therapy of severe abdominal infections. A multicenter study.
Topics: Bacterial Infections; Ceftazidime; Cilastatin; Cyclopropanes; Digestive System Diseases; Dipeptidases; Drug Evaluation; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Random Allocation; Thienamycins | 1987 |
Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Middle Aged; Peritonitis; Random Allocation; Thienamycins | 1987 |
Treatment of intra-abdominal infections using imipenem/cilastatin.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Peritonitis | 1987 |
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
Topics: Abdomen; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Infections; Infusions, Intravenous; Metronidazole; Middle Aged; Treatment Outcome | 1996 |
A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
Topics: Abdomen; Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefuroxime; Cilastatin; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 1996 |
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome | 1997 |
Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
Topics: Abdomen; Aged; Anti-Infective Agents; Bacterial Infections; Cilastatin; Ciprofloxacin; Cost-Benefit Analysis; Double-Blind Method; Drug Combinations; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Protease Inhibitors; Thienamycins | 1999 |
A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
Topics: Abdominal Cavity; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Hospitals, University; Humans; Imipenem; Male; Metronidazole; Middle Aged | 2007 |
8 other study(ies) available for metronidazole and cilastatin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins | 1991 |
Management of necrotizing fasciitis in the neck.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cilastatin; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Fasciitis, Necrotizing; Focal Infection, Dental; Gentamicins; Humans; Hyperbaric Oxygenation; Imipenem; Male; Metronidazole; Neck; Penicillins; Protease Inhibitors; Thienamycins | 1996 |
[Otogenic intracranial abscesses. Description of 6 cases].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Otitis Media; Tomography, X-Ray Computed | 2004 |
The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection.
Topics: Adult; Aged; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Imipenem; Male; Metronidazole; Middle Aged; Probability; Retrospective Studies; Treatment Outcome | 2004 |
Tetratrichomonas in pyopneumothorax.
Topics: Aged, 80 and over; Antiprotozoal Agents; Cilastatin; Empyema, Pleural; Female; Humans; Imipenem; Metronidazole; Pleural Effusion; Pneumothorax; Streptococcal Infections; Streptococcus anginosus; Trichomonadida; Trichomonas Infections | 2019 |